1,089 Shares in UnitedHealth Group Incorporated (NYSE:UNH) Bought by Impact Investors Inc

Impact Investors Inc acquired a new position in UnitedHealth Group Incorporated (NYSE:UNH) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund acquired 1,089 shares of the healthcare conglomerate’s stock, valued at approximately $551,000.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in UNH. Sabal Trust CO boosted its holdings in UnitedHealth Group by 0.7% in the 4th quarter. Sabal Trust CO now owns 61,926 shares of the healthcare conglomerate’s stock valued at $31,326,000 after purchasing an additional 443 shares during the period. National Pension Service lifted its stake in shares of UnitedHealth Group by 1.6% in the fourth quarter. National Pension Service now owns 1,731,922 shares of the healthcare conglomerate’s stock valued at $876,110,000 after buying an additional 27,362 shares during the period. Fjell Capital LLC bought a new position in UnitedHealth Group during the fourth quarter valued at about $857,000. Lingotto Investment Management LLP acquired a new stake in shares of UnitedHealth Group during the 4th quarter worth approximately $3,597,000. Finally, FFT Wealth Management LLC raised its stake in shares of UnitedHealth Group by 13.0% in the fourth quarter. FFT Wealth Management LLC now owns 1,456 shares of the healthcare conglomerate’s stock valued at $736,000 after purchasing an additional 168 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently issued reports on the stock. Hsbc Global Res upgraded shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research note on Friday, January 10th. StockNews.com upgraded UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Thursday, January 23rd. Truist Financial lowered their price target on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a research report on Monday, January 6th. Cantor Fitzgerald restated an “overweight” rating and issued a $700.00 target price on shares of UnitedHealth Group in a research note on Friday, January 17th. Finally, Stephens lifted their price target on shares of UnitedHealth Group from $605.00 to $675.00 and gave the company an “overweight” rating in a report on Thursday, December 5th. One investment analyst has rated the stock with a hold rating, twenty have given a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat, UnitedHealth Group currently has a consensus rating of “Buy” and an average price target of $629.32.

Insider Transactions at UnitedHealth Group

In other news, Director Timothy Patrick Flynn acquired 1,000 shares of the firm’s stock in a transaction that occurred on Friday, January 17th. The stock was acquired at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the acquisition, the director now owns 4,500 shares in the company, valued at $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 0.33% of the stock is owned by insiders.

UnitedHealth Group Stock Performance

Shares of UNH stock opened at $470.49 on Wednesday. The stock has a market cap of $432.99 billion, a PE ratio of 30.35, a price-to-earnings-growth ratio of 1.37 and a beta of 0.61. The stock has a 50-day moving average of $518.22 and a 200-day moving average of $559.08. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $630.73.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business had revenue of $100.81 billion during the quarter, compared to analysts’ expectations of $101.60 billion. During the same quarter in the prior year, the company earned $5.83 EPS. The firm’s quarterly revenue was up 6.8% on a year-over-year basis. As a group, sell-side analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th will be paid a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a yield of 1.79%. The ex-dividend date is Monday, March 10th. UnitedHealth Group’s payout ratio is currently 54.19%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.